Graft Vs Host Disease
📧 Sign up to get email alerts when something new happens for Graft Vs Host Disease.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2020-02-17EMA Application withdrawn: Luxceptar — Kiadis Pharma Netherlands B.V.
EMA status shows that the Luxceptar application has been withdrawn by the applicant.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults [Phase 2]
Phase 2 trial investigating an immunosuppressive regimen followed by blood cell transplant for treating blood cancers in older adults; compl…